AmerisourceBergen's focus is always on the customer

July 2012
Chain Drug Review;7/16/2012, Vol. 34 Issue 12, p35
Trade Publication
The article focuses on AmerisourceBergen Corp., which has witnessed development in the areas significant for the future of pharmacy, generic drugs, and the needs of customers and patients. AmerisourceBergen's PRxO Generics Solutions initiative and other programs have been designed to enable pharmacies and patients to reap the maximum benefit from such medications by creating customized product portfolios.


Related Articles

  • Generics makers fight brand-name competition from "authorized" drugs. Wechsler, Jill // Managed Healthcare Executive;Sep2006, Vol. 16 Issue 9, p10 

    The article reports on the competition between generic drug makers and brand-name firms who are putting out their own authorized generic products. This move by the brand-name companies undercuts the innovator's price but it hurts the generics firms by reducing the value of the 180-day...

  • Not exactly what the doctor ordered. Troy, Terry // Dermatology Times;Jan1999, Vol. 20 Issue 1, p14 

    Focuses on a survey of several pharmacies in Cleveland, Ohio conducted by `Dermatology Times' periodical after receiving complaints that pharmacists substitute generic and over-the-counter products for prescribed medicine. Response of a regional discount drug chain and three national drug...

  • Generics provide impetus for customers.  // Chain Drug Review;10/12/2009, Vol. 31 Issue 17, p52 

    The article reports on the role of generic drugs in how AmerisourceBergen Corp. help retailers in Forge, Pennsylvania. It states that company executives have been quick to develop ways to provide customers a competitive edge. It notes that the firm's PRxO program was specifically developed to...

  • Best may be yet to come for generic drug makers. Kirsche, Michelle L. // Drug Store News;2/14/2005, Vol. 27 Issue 2, p28 

    Reports on the research-and-development pipeline of drug makers in the U.S. Sales of generic companies; Factors contributing to the performance of drug makers; Development of generic pipeline.

  • GPhA bullish on generic industry's future. Cohen, Harold E. // Drug Topics;5/7/2001, Vol. 145 Issue 9, p64 

    Provides information on the Generic Pharmaceutical Association (GPhA), a unification of the generic industry in the United States. Significance of the formation of a united front for the generic industry; Goals of the association; Strategy of pharmacy benefit managers.

  • Is the Generics Industry Ready for Multi-Source Biologics? Challener, Cynthia // Chemical Market Reporter;04/23/2001, Vol. 259 Issue 17, p14 

    Deals with the generic biologic industry. Estimated growth of the biopharmaceutical generics market; Details on the acquisition of Indiana Protein Technologies by Ivax Corp.; European firms preparing to participate in the marketing and sales of generic biopharmaceuticals; Risks faced by a...

  • SEE pharmaceutical market healthy in 2010. Stamov, Valentin; Pavlova, Iskra // SEE Top 100;2011, p46 

    The article focuses on the condition of the pharmaceutical market in 2010 in Southeast Europe (SEE). It notes that sales of pharmaceuticals in the SEE region are influenced by generic drugs. It claims that there is a growth in the pharmaceutical market in Bulgaria in terms of value. It also...

  • Keeping costs down. Hlaves, Dale W. // Smart Business Akron/Canton;Jun2009, Vol. 19 Issue 1, p34 

    An interview with pharmacy executives Michelle Dittrich and Tracy Dankoff is presented. When asked what integrated pharmacy management (PM) is, they reply that it is a way of managing a prescription drug plan including building a pharmacy network and determining the most appropriate plan for...

  • 'Broken' branded pipeline opens new generics pathways. Frederick, James // Drug Store News;9/26/2005, Vol. 27 Issue 12, p55 

    Reports that a slowdown in sales growth continues to plague the branded pharmaceutical industry in the United States. Claim by Doug Long, an industry expert from IMS Health; Competition from generic drugs; Need for branded companies to replace the lost products with new ones; Difficulty of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics